YAKUODO HOLDINGS stock has been drifting lower for weeks, yet today’s earnings force a harder look at what the market is really pricing. The share price closed at ¥1,563 after a stretch of weaker short term returns, while the business just posted quarterly revenue of ¥45,722 million and Basic EPS of ¥63.44. That move feels more emotional than analytical. The headline is simple for a drugstore operator: solid top line and earnings, set against a trailing P/E around 8.2x and a thinner 2.2% net margin that keeps investors on edge.
Is YAKUODO HOLDINGS trading like a bargain value stock, or simply wearing a low P/E because the market does not trust its slim 2.2% margin and DCF gap to price? Compare that story against the full valuation analysis for YAKUODO HOLDINGS
Q2 2027 Earnings Summary
- Revenue (Q2 2027 vs. Q2 2026): ¥45,722 million vs. ¥43,413 million (top line higher year on year)
- Net Income (Q2 2027 vs. Q2 2026): ¥1,234 million vs. ¥1,416 million (profit lower year on year)
- Basic EPS (Q2 2027 vs. Q2 2026): ¥63.44 vs. ¥72.50 (per share earnings declined year on year)
- Trailing Net Profit Margin (latest vs. prior year): 2.2% vs. 2.8% (margin compressed over the last 12 months)
Prefer clean, visual charts over a wall of raw earnings numbers for YAKUODO HOLDINGS? See the company’s full financial picture, including how its valuation compares with recent results, in the interactive company report for YAKUODO HOLDINGS.
YAKUODO HOLDINGS and the bullish defensives story
For anyone leaning toward a defensive thesis on YAKUODO HOLDINGS, the top line helps. Revenue in Q2 2027 sits above Q2 2026, which fits the idea of steady demand for everyday health and household products. That matters for investors who care more about resilience than excitement. The latest quarter still delivers positive earnings and Basic EPS, so the model is generating profit. Even with short term share price weakness over 7, 30 and 90 days, the business itself continues to sell more goods year on year.
Margin squeeze keeps the bearish angle alive
The bear story does not fall apart. YAKUODO HOLDINGS reports lower net income and softer Basic EPS than a year earlier, and the trailing net margin has slipped from 2.8% to 2.2%. That pattern fits concerns about tougher competition and limited pricing power in Japanese drugstores. Returns over the last 3 months have also drifted lower, which suggests investors are not ignoring that profitability pressure. Revenue growth helps, but the thinner margin keeps risk focused on whether this retailer can protect earnings when promotional intensity or costs rise further.
After a margin squeeze like this, you should ask whether thin profitability is masking deeper balance sheet issues. Review our risk analysis for YAKUODO HOLDINGS which shows 2 important warning signs.Take Charge Of Your Next Move
With YAKUODO HOLDINGS posting higher revenue but tighter margins, it can make sense to register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value before deciding on an entry point. Once you hold the stock, use the Portfolio Command Center to cut through noise and focus on the updates that genuinely affect your investment. For a wider lens on what other investors are seeing, lean on the Community to compare different views and questions in one place. That way you can spot potential catalysts and risks early and keep a step ahead of where the market moves next.
Seeking Fresh Alternatives Beyond YAKUODO HOLDINGS
New themes can start to break out while attention stays fixed on a single ticker. Scan fresh ideas with real momentum before the crowd catches them and act now.
- Chase reliable income streams while rates and sentiment keep shifting by scanning a curated set of 21 dividend fortresses that aim to keep payouts flying.
- Spot early AI momentum before enthusiasm peaks by reviewing 36 profitable AI stocks that aren't just burning cash that already back their story with real earnings instead of burning cash.
- Track the backbone of future computing by checking 24 quantum computing stocks that are building the picks and shovels for tomorrow’s quantum breakthroughs while they are still under the radar for now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com